| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |